New Antibiotic Approved: Vabomere

Recently an Intravenous antibiotic called Vabomere was approved by FDA. It is a combination of vaborbactam and meropenem. Its indication includes UTIs. This combination will help us to fight against more serious bacterial infections of the urinary tract.  

The clinical trials were done on around 550 peoples suffering from complicated UTI. Out of these, 98% of people were recovered from it. The side effect profile of this combination antibiotic includes headache and diarrhea. Moreover, allergic reactions at the site of injection or severe allergic reaction in the body can also be encountered.


It will be effective against a wide range of bacteria, but to avoid its resistance it should only be used after a proper culture test against the susceptible bacteria. It will be manufactured by Rempex Pharmaceuticals (San Diego).

Comments

Popular posts from this blog

Clarinase

Death- By Neglect or by Design

Arthri-flex